TCG CROSSOVER MANAGEMENT, LLC Cogent Biosciences, Inc. Transaction History

TCG CROSSOVER MANAGEMENT, LLC portfolio value:

$51.93M
portfolio value

TCG CROSSOVER MANAGEMENT, LLC quarter portfolio value change:

+65.41%
quarter

Cogent Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 20.53M $14.92 3.48M
Q2 2022 share Increase +16.77% 500K shares 9.07M $9.02 3.48M
Q1 2022 share Increase +8.40% 231.00K shares -1.26M $7.49 2.98M
Q4 2021 share Increase 0.00% 2.75M shares 23.59M $8.56 2.75M